News Between Reporter

The recent FDA approval of neffy epinephrine nasal spray marks a significant milestone in the field of allergy treatment. This innovative non-injectable emergency solution offers a new pathway for managing type I allergic reactions, including anaphylaxis, without the need for needles. Developed by ARS Pharmaceuticals, neffy has been designed to provide swift and effective relief